Niagen Bioscience Inc (NAGE) returns
Niagen Bioscience returns over 10 years
$1,000 invested in Niagen Bioscience ten years ago was worth $814.69 at the close on October 30, 2026, with dividends reinvested: an average return of -2.0% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -20.2% | — | $797.95 | -0.9% |
| 3 months | -29.8% | — | $701.81 | +2.1% |
| Year to date | -63.4% | — | $366.35 | +11.7% |
| 1 year | -67.2% | — | $327.71 | +12.4% |
| 3 years | +76.5% | +20.9% | $1,765 | +88.5% |
| 5 years | -62.4% | -17.8% | $376.41 | +76.0% |
| 10 years | -18.5% | -2.0% | $814.69 | +316.6% |
Niagen Bioscience return by calendar year
| Year | NAGE | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -63.4% | +11.7% | -75.1% |
| 2025 | +19.9% | +17.7% | +2.2% |
| 2024 | +271.0% | +24.9% | +246.1% |
| 2023 | -14.9% | +26.2% | -41.1% |
| 2022 | -55.1% | -18.2% | -36.9% |
| 2021 | -22.1% | +28.7% | -50.8% |
| 2020 | +11.4% | +18.4% | -7.0% |
| 2019 | +25.7% | +31.2% | -5.6% |
| 2018 | -41.7% | -4.6% | -37.1% |
| 2017 | +77.6% | +21.7% | +55.9% |
| 2016 | -9.6% | +12.0% | -21.6% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: NAGE financials · NAGE valuation
No forecast, no recommendation. This page describes Niagen Bioscience Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.